Cargando…

Correction: König et al. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics 2021, 10, 649

Detalles Bibliográficos
Autores principales: König, Christina, Both, Anna, Rohde, Holger, Kluge, Stefan, Frey, Otto R., Röhr, Anka C., Wichmann, Dominic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532813/
https://www.ncbi.nlm.nih.gov/pubmed/34680855
http://dx.doi.org/10.3390/antibiotics10101230
_version_ 1784587159132438528
author König, Christina
Both, Anna
Rohde, Holger
Kluge, Stefan
Frey, Otto R.
Röhr, Anka C.
Wichmann, Dominic
author_facet König, Christina
Both, Anna
Rohde, Holger
Kluge, Stefan
Frey, Otto R.
Röhr, Anka C.
Wichmann, Dominic
author_sort König, Christina
collection PubMed
description
format Online
Article
Text
id pubmed-8532813
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85328132021-10-23 Correction: König et al. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics 2021, 10, 649 König, Christina Both, Anna Rohde, Holger Kluge, Stefan Frey, Otto R. Röhr, Anka C. Wichmann, Dominic Antibiotics (Basel) Correction MDPI 2021-10-09 /pmc/articles/PMC8532813/ /pubmed/34680855 http://dx.doi.org/10.3390/antibiotics10101230 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
König, Christina
Both, Anna
Rohde, Holger
Kluge, Stefan
Frey, Otto R.
Röhr, Anka C.
Wichmann, Dominic
Correction: König et al. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics 2021, 10, 649
title Correction: König et al. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics 2021, 10, 649
title_full Correction: König et al. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics 2021, 10, 649
title_fullStr Correction: König et al. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics 2021, 10, 649
title_full_unstemmed Correction: König et al. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics 2021, 10, 649
title_short Correction: König et al. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics 2021, 10, 649
title_sort correction: könig et al. cefiderocol in critically ill patients with multi-drug resistant pathogens: real-life data on pharmacokinetics and microbiological surveillance. antibiotics 2021, 10, 649
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532813/
https://www.ncbi.nlm.nih.gov/pubmed/34680855
http://dx.doi.org/10.3390/antibiotics10101230
work_keys_str_mv AT konigchristina correctionkonigetalcefiderocolincriticallyillpatientswithmultidrugresistantpathogensreallifedataonpharmacokineticsandmicrobiologicalsurveillanceantibiotics202110649
AT bothanna correctionkonigetalcefiderocolincriticallyillpatientswithmultidrugresistantpathogensreallifedataonpharmacokineticsandmicrobiologicalsurveillanceantibiotics202110649
AT rohdeholger correctionkonigetalcefiderocolincriticallyillpatientswithmultidrugresistantpathogensreallifedataonpharmacokineticsandmicrobiologicalsurveillanceantibiotics202110649
AT klugestefan correctionkonigetalcefiderocolincriticallyillpatientswithmultidrugresistantpathogensreallifedataonpharmacokineticsandmicrobiologicalsurveillanceantibiotics202110649
AT freyottor correctionkonigetalcefiderocolincriticallyillpatientswithmultidrugresistantpathogensreallifedataonpharmacokineticsandmicrobiologicalsurveillanceantibiotics202110649
AT rohrankac correctionkonigetalcefiderocolincriticallyillpatientswithmultidrugresistantpathogensreallifedataonpharmacokineticsandmicrobiologicalsurveillanceantibiotics202110649
AT wichmanndominic correctionkonigetalcefiderocolincriticallyillpatientswithmultidrugresistantpathogensreallifedataonpharmacokineticsandmicrobiologicalsurveillanceantibiotics202110649